IUPHAR themed review: The gut microbiome in schizophrenia
Gut microbial dysbiosis or altered gut microbial consortium, in schizophrenia suggests a pathogenic role through the gut-brain axis, influencing neuroinflammatory and neurotransmitter pathways critical to psychotic, affective, and cognitive symptoms. Paradoxically, conventional psychotropic interven...
Saved in:
| Main Authors: | Srinivas Kamath, Elysia Sokolenko, Kate Collins, Nicole S.L. Chan, Natalie Mills, Scott R. Clark, Francine Z. Marques, Paul Joyce |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661824005061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia
by: Paula M. Moran, et al.
Published: (2025-06-01) -
Dysbiosis and Schizophrenia: A Review of Current Evidence on the Gut–Brain Axis and Probiotic Interventions
by: Anna Jakubiak, et al.
Published: (2025-05-01) -
Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01) -
The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China
by: Huaning Wang, et al.
Published: (2025-07-01) -
Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
by: Isnenia Isnenia
Published: (2022-03-01)